XML 56 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation Share-Based Compensation (Details 2) (SARs [Member])
In Millions, except Share data, unless otherwise specified
6 Months Ended 12 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2014
Sep. 30, 2014
Hindalco SARs [Member]
USD ($)
Sep. 30, 2014
Hindalco SARs [Member]
INR
Sep. 30, 2013
Hindalco SARs [Member]
Mar. 31, 2014
Hindalco SARs [Member]
USD ($)
Mar. 31, 2014
Hindalco SARs [Member]
INR
Sep. 30, 2014
Novelis SARs [Member]
USD ($)
Sep. 30, 2013
Novelis SARs [Member]
Mar. 31, 2014
Novelis SARs [Member]
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.64% 0.64% 1.25%     0.00% 0.00%  
Number of SARs                  
Outstanding as of beginning of period (shares)   21,635,392 21,635,392       668,402    
Granted (shares)   4,981,611 4,981,611       384,896    
Exercised (shares)   (5,199,644) (5,199,644)       (20,720)    
Forfeited/Cancelled (shares)   (1,074,951) (1,074,951)       (51,629)    
Outstanding as of end of period (shares)   20,342,408 20,342,408   21,635,392 21,635,392 980,949   668,402
Shares exercisable as of end of period   7,188,545 7,188,545       211,768    
Weighted Average Exercise Price                  
Outstanding as of beginning of period     112.26       $ 90.09    
Granted     145.50       $ 94.40    
Exercised     90.56       $ 72.00    
Forfeited/Cancelled     129.04       $ 86.85    
Outstanding as of end of period     125.06     112.26 $ 92.33   $ 90.09
Exercisable as of end of period     125.66       $ 89.31    
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Aggregate Intrinsic Value, Exercised   $ 0              
Weighted Average Remaining Contractual Term, Outstanding as of beginning of period   4 years 9 months 4 years 9 months   4 years 4 months 4 years 4 months 5 years 7 months   5 years 4 months
Weighted Average Remaining Contractual Term, Granted The amount of cash paid to settle Hindalco SARs and Novelis SARs are limited to two and a half or three times the target payout P6Y7M P6Y7M       P6Y7M    
Weighted Average Remaining Contractual Term, Outstanding as of end of period   4 years 9 months 4 years 9 months   4 years 4 months 4 years 4 months 5 years 7 months   5 years 4 months
Weighted Average Remaining Contractual Term, Exercisable as of end of period   3 years 1 month 3 years 1 month       4 years 7 months    
Aggregate Intrinsic Value, Outstanding as of beginning of period   13         2    
Aggregate Intrinsic Value, Granted   0         0    
Aggregate Intrinsic Value, Outstanding as of end of period   13     13   3   2
Aggregate Intrinsic Value, Exercisable as of end of period   $ 5         $ 2